Mushroom Research Hub
Research summaries built from peer-reviewed studies — making mushroom science accessible. Covers psilocybin, functional mushrooms, neuroscience, pharmacology, and more. Podcasts, video animations, narrated slides, and study guides.
📚 View Annotated Bibliography — all 62 peer-reviewed sources42 resources
▶ VideoCanada's Psilocybin Patients: Compassionate Access & Real-World Outcomes
An overview of how Canadian patients have accessed psilocybin through Health Canada's Special Access Program — covering eligibility, the clinical framework, patient-reported outcomes, and what real-world use reveals about psilocybin's therapeutic promise beyond controlled trial settings.
Watch →
▶ VideoChallenging Psilocybin Experiences: What Research Tells Us About Difficult Trips
A research-grounded look at why some psilocybin sessions become challenging or frightening — covering neuroticism as a predictor of adverse reactions, the role of set and setting, and how clinical protocols minimize risk while preserving therapeutic potential.
Watch →
▶ VideoCompassionate Psilocybin: Access Programs, Patient Eligibility & Clinical Context
An exploration of compassionate access frameworks for psilocybin — examining who qualifies, how clinicians apply for exemptions, the therapeutic setting requirements, and what patient outcomes data tell us about psilocybin's role beyond clinical trials.
Watch →
▶ VideoHealing With Psilocybin: Clinical Evidence for Lasting Therapeutic Change
A synthesis of the clinical evidence for psilocybin-assisted therapy — covering randomized controlled trial outcomes, neuroplasticity mechanisms including dendritic spine growth, and what long-term follow-up data reveals about the durability of therapeutic change.
Watch →
▶ VideoInside a Psilocybin Clinical Trial: Protocol, Patient Experience & Outcomes
An inside look at what actually happens in a psilocybin clinical trial — from screening and preparation sessions through the guided dosing session and integration, drawing on protocols from Johns Hopkins and Imperial College London and patient testimony from peer-reviewed qualitative research.
Watch →
▶ VideoInside Magic Mushrooms: The Chemistry, Species, and Science of Psilocybin
A science-focused breakdown of what magic mushrooms actually contain — covering psilocybin's conversion to psilocin, species variation in potency, DNA authentication findings, pharmacokinetics, and the 5-HT2A receptor agonism that drives psychedelic effects.
Watch →
▶ VideoLong COVID & Psychedelics: Can Psilocybin and MDMA Support Recovery?
An examination of emerging evidence for psychedelic-assisted therapy in Long COVID — including the published case report of MDMA and psilocybin reversing persistent Long-COVID symptoms, proposed mechanisms involving neuroinflammation and serotonin signaling, and the research agenda this opens.
Watch →
▶ VideoMagic Mushrooms: A Reality Check on the Science, Hype, and Evidence
A balanced, evidence-based assessment of magic mushroom science — separating well-supported findings from premature claims, examining the quality of existing clinical trial evidence, and asking what rigorous research actually shows versus what enthusiasts and critics overstate.
Watch →
▶ VideoMushroom Science vs. Hype: Evaluating Psilocybin Research with a Critical Eye
A critical examination of the gap between enthusiastic popular coverage of psilocybin research and what peer-reviewed evidence actually supports — covering trial design limitations, publication bias, dose-response nuance, and how to read psychedelic research skeptically without dismissing genuine findings.
Watch →
▶ VideoNeuroticism and the 'Bad Trip': Why Personality Predicts Challenging Psilocybin Experiences
A research-driven exploration of why personality — particularly neuroticism — is the strongest psychological predictor of challenging or frightening psilocybin experiences. Covers Barrett et al.'s foundational study, the Big Five model in psychedelic research, and how screening protocols use personality data to improve safety.
Watch →
▶ VideoThe Pillars of Psilocybin Therapy: Set, Setting, Integration & Guide Relationship
An overview of the four pillars that define effective psilocybin-assisted therapy — mindset preparation, environmental design, the therapeutic relationship with guides, and post-session integration — drawing on clinical trial protocols and qualitative patient experience research.
Watch →
▶ VideoPromise & Puzzle: The Science and Open Questions of the Psilocybe Genus
An exploration of the Psilocybe genus — covering species diversity, the puzzle of inconsistent potency across specimens, DNA authentication findings that expose mislabeling in fungaria, and what open questions remain in Psilocybe taxonomy and chemistry.
Watch →
▶ VideoPsilocybin & Bipolar Disorder: Weighing the Evidence on Risks and Reported Benefits
A thorough examination of what the largest available dataset — an international survey of 541 people with bipolar disorder who have used psilocybin — reveals about the balance of benefits and risks, including the documented incidence of manic episodes and what clinical researchers now recommend for this population.
Watch →
▶ VideoPsilocybin & Bipolar Disorder: A Research Overview
A concise overview of the current state of research on psilocybin use in people with bipolar disorder — covering why bipolar patients are typically excluded from clinical trials, survey evidence of both benefits and harms, and the research gaps that make this a high-priority area for future investigation.
Watch →
▶ VideoPsilocybin & Mystical Experiences: The Science of Profound States of Consciousness
A scientific examination of psilocybin-occasioned mystical experiences — what they are, how they're measured (MEQ-30), why their intensity predicts therapeutic outcomes, and what Griffiths et al.'s foundational study revealed about the lasting personal and spiritual significance of high-dose psilocybin.
Watch →
▶ VideoPsilocybin Therapy: From Clinical Trials to Emerging Therapeutic Applications
A broad overview of psilocybin as a therapeutic agent — tracing the arc from Griffiths' 2006 mystical experience study through landmark randomized controlled trials for depression, with a look at the conditions now under active clinical investigation including addiction, OCD, and end-of-life distress.
Watch →
▶ VideoThe Microdosers' Journey: What Research Reveals About Sub-Perceptual Psilocybin
An evidence-grounded look at microdosing psilocybin — covering Hughes et al.'s dynamic processual model of how microdosing practice evolves through initiation, active use, integration, and adaptation, and why individual outcomes vary far more than popular accounts suggest.
Watch →
🎙 PodcastBipolar Patients & Psilocybin: Understanding the Risk of Mania
A podcast exploring the specific risk of manic or hypomanic episodes in people with bipolar disorder who use psilocybin — drawing on survey data from 541 bipolar patients and discussing what screening, monitoring, and harm reduction protocols researchers now recommend.
Listen →
🎙 PodcastHow Psilocybin's Mystical Experiences Treat Depression: Mechanisms Explained
A podcast unpacking the proposed mechanism by which psilocybin-occasioned mystical experiences produce antidepressant effects — covering disruption of the default mode network, emotional processing changes measured by fMRI, and why the intensity of the mystical experience predicts the magnitude of antidepressant response.
Listen →
🎙 PodcastHow Psilocybin Transforms Deep Psychological Suffering: Research & Patient Perspectives
A podcast synthesizing clinical and qualitative research on psilocybin's capacity to transform existential suffering — drawing on patient testimony from a qualitative meta-synthesis of multiple clinical studies and the neuroplasticity evidence showing structural brain changes after psilocybin treatment.
Listen →🎙 PodcastLegal Psilocybin for Terminal Cancer Patients: Compassionate Access & End-of-Life Care
A podcast examining the growing movement to make psilocybin legally available to terminally ill patients — covering the history of end-of-life psilocybin research from Griffiths' 2006 mystical experience study through current compassionate access programs, and what clinical evidence supports its use in existential distress at end of life.
Listen →
🎙 PodcastMagic Mushrooms Have Unique Chemical Fingerprints: DNA Authentication & Potency Science
A podcast exploring the landmark finding that Psilocybe mushroom specimens — even within the same species — carry unique chemical fingerprints, with psilocybin and related alkaloid content varying dramatically across strains. Based on Bradshaw et al.'s DNA authentication study of international fungaria.
Listen →
🎙 PodcastMDMA & Psilocybin Reverse Long-COVID Symptoms: The Case Report Explained
A podcast breaking down the published clinical case report of a Long-COVID patient whose persistent fatigue, brain fog, and post-exertional malaise substantially resolved following MDMA and psilocybin-assisted therapy — examining proposed mechanisms and what this single case means for the emerging research agenda.
Listen →
🎙 PodcastStandardizing Psilocybin for Pharmaceutical Precision: Chemistry, Dosing & Authentication
A podcast on the science of pharmaceutical-grade psilocybin standardization — covering why natural mushroom potency varies so widely, how DNA authentication can verify species identity, psilocybin's pharmacokinetics and dose-response relationship, and what standardization means for clinical trial replicability.
Listen →🎙 PodcastWhy Neuroticism Triggers Bad Mushroom Trips: Personality Science & Harm Reduction
A podcast exploring the neuroscience and psychology of why neuroticism predicts challenging psilocybin experiences — covering the Big Five personality model, Barrett et al.'s study findings, what high-neuroticism individuals experience during difficult sessions, and practical harm reduction implications for screening.
Listen →
🎙 PodcastWhy Ordinary People Risk Illegal Microdosing: Motivations, Experiences & Research
A podcast examining why significant numbers of people with no prior psychedelic experience or clinical recommendation choose to microdose psilocybin illegally — drawing on Hughes et al.'s research into motivations, reported benefits and harms, and what the dynamic, evolving nature of microdosing practice reveals about unmet mental health needs.
Listen →🎙 PodcastWhy the Worst Trips Change Lives: Transformative Power of Challenging Experiences
A podcast examining the paradox that some of the most therapeutically meaningful psilocybin experiences are also the most difficult — drawing on Griffiths' mystical experience research, patient qualitative testimony from clinical studies, and what the relationship between difficulty and transformation reveals about psilocybin's mechanism.
Listen →
▶ VideoFunctional Mushrooms Explained: A Complete Research Overview
An accessible, jargon-free video overview of functional mushroom science — covering Lion's Mane, Turkey Tail, Reishi, Cordyceps, and Shiitake. Based on 20 peer-reviewed sources, this video explores bioactive compounds (beta-glucans, polysaccharides, triterpenoids), immune modulation, neuroprotection, gut health, and athletic performance in plain language anyone can understand.
Watch →
▶ VideoMushrooms & Depression: Can Lion's Mane, Reishi & Cordyceps Support Mental Health?
A research-driven exploration of how specific medicinal mushrooms — particularly Lion's Mane, Reishi, and Cordyceps — may support mental health through serotonin precursors (5-HTP), adaptogenic HPA axis regulation, BDNF upregulation, and anti-inflammatory pathways. Based on the peer-reviewed literature on edible mushrooms as dietary interventions for major depressive disorder.
Watch →
▶ VideoMushrooms in Skincare: Reishi & Shiitake as Cosmeceuticals
An educational overview of how fungi — particularly Reishi (Ganoderma lucidum) and Shiitake (Lentinula edodes) — are used in the cosmetics industry as cosmeceuticals and nutricosmetics. Covers beta-glucan moisturization, antioxidant anti-aging mechanisms, skin-whitening compounds (kojic acid, arbutin), and how fungal extracts are being integrated into modern dermatology-grade skincare products.
Watch →
▶ VideoFunctional Mushrooms: Bioactive Compounds, Health Benefits & Research Overview
An AI-generated educational video exploring the science of functional mushrooms — including Lion's Mane, Turkey Tail, Reishi, Cordyceps, and Shiitake. Based on 17 peer-reviewed studies, this overview covers bioactive compounds (β-glucans, polysaccharides, triterpenoids), immune modulation, neuroprotection, gut health, and the evolving role of medicinal mushrooms in modern pharmacology and functional food science.
Watch →
▶ VideoLion's Mane & Neurogenesis: NGF, BDNF, and Cognitive Health
A deep-dive into the science behind Lion's Mane (Hericium erinaceus) and its unique capacity to stimulate Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) synthesis. Covers the blood-brain-barrier-crossing erinacines, double-blind clinical trials on cognitive impairment, mood and sleep improvements in obese adults, and emerging Alzheimer's prevention research.
Watch →
▶ VideoReishi: Adaptogenic Stress Response, Immune Modulation & Longevity
An evidence-based overview of Reishi (Ganoderma lucidum) — the 'mushroom of immortality' — examining its triterpenoids and polysaccharides, cortisol-lowering HPA-axis modulation, TLR4-driven macrophage activation, cancer cell apoptosis, and clinical trial results for fatigue, neurasthenia, and quality of life in cancer survivors.
Watch →
▶ VideoTurkey Tail, PSK & Immune Defense: Clinical Evidence in Oncology
A research-backed look at Turkey Tail (Trametes versicolor) — one of the most clinically studied medicinal mushrooms. Covers PSK (Krestin) and PSP mechanism of action via TLR2/TLR4, macrophage M1/M2 repolarization, Phase I breast cancer trial outcomes, HPV regression data, and why it's the only mushroom extract approved as an adjunct cancer therapy in Japan.
Watch →
▶ VideoCordyceps: Cellular Energy, VOâ‚‚ Max & Athletic Performance
An evidence-based breakdown of Cordyceps militaris and Ophiocordyceps sinensis — from cordycepin's AMPK activation and ATP synthesis to peer-reviewed athletic performance trials, antidepressant mechanisms via BDNF upregulation, and blood-sugar regulation. Includes double-blind VO₂ max study results and the ongoing ClinicalTrials.gov mood trial.
Watch →
▶ VideoShiitake, Lentinan & Eritadenine: Immune Defense and Cardiovascular Health
A research-led overview of Shiitake (Lentinula edodes) — covering lentinan's Dectin-1 / MAPK-NF-κB immune activation pathway, 12 years of clinical use as a cancer immunotherapy adjunct in China, eritadenine's dose-dependent LDL cholesterol reduction, and how shiitake polysaccharides support gut microbiome health.
Watch →
▶ VideoPsilocybin Research: A Comprehensive Overview
An animated video overview of current psilocybin research, covering clinical outcomes, mystical-type experiences, safety considerations, microdosing models, species identification, and emerging therapeutic applications. Based on 8 peer-reviewed studies sourced from Google Scholar.
Watch →
🎙 PodcastPsilocybin Research: A Comprehensive Overview (Podcast)
A conversational audio deep-dive into current psilocybin research — covering clinical outcomes, mystical-type experiences, safety considerations, microdosing models, species identification, and emerging therapeutic applications. Ideal for commutes and curious minds. Based on 8 peer-reviewed studies sourced from Google Scholar.
Listen →
🎙 PodcastPsilocybin & Neuroplasticity: An AI Research Overview
An AI-generated audio deep-dive into emerging research on psilocybin's role in promoting structural and functional neuroplasticity — including synaptogenesis, default mode network disruption, and what brain imaging studies reveal about lasting therapeutic effects.
Listen →▶ VideoClinical Trials: Psilocybin for Treatment-Resistant Depression
An animated educational video summarizing landmark clinical trials — including COMPASS Pathways Phase 2b and Johns Hopkins studies — exploring how psilocybin-assisted therapy compares to conventional antidepressants in treatment-resistant patients.
Watch →
📊 Narrated SlidesThe Pharmacology of Psilocybin: From Ingestion to Effect
Narrated slides tracing psilocybin's pharmacokinetic journey — from dephosphorylation to psilocin, 5-HT2A receptor agonism, and the downstream serotonergic cascade. Designed for researchers and students approaching psychedelic pharmacology for the first time.
Watch →
📄 DocumentPsilocybin Safety Profile: A Research Study Guide
A comprehensive research document summarizing psilocybin's physiological and psychological safety profile across clinical studies. Covers acute adverse effects, contraindications, long-term safety data, and regulatory considerations for research contexts.
Read →Shop Mushroom Spores & Cultures
Laboratory-grade Psilocybe cubensis spore syringes and functional mushroom cultures for microscopy research. Contaminant-free guarantee, discreet shipping.
Shop Spore Syringes →